
Late Breast Cancer Recurrence Prediction: The Role of CTS5 and Progesterone Receptor Status
Introduction In 2024, breast cancer alone is estimated to account for nearly one-third of all new cancer cases diagnosed in women.1 Over 60% of female patients with breast cancer are diagnosed with localized disease, with up to 70% of cases classified as …